4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-067659
EVP, Research & CSO sold 15,125 shares at an average $49.60 ($750,200)
- EVP, Research & CSO acquired 15,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-30 | Exercise or conversion : show line 1 in the form | +15,125 | $1.53 | $23,141 | 122,825 | D |
| 2021-11-30 | Sale : show line 2 in the form | −1,375 | $45.60 | $62,700 | 121,450 | D |
| 2021-11-30 | Sale : show line 3 in the form | −13,750 | $50.00 | $687,500 | 107,700 | D |
| Open-market sales · 15,125 sh · avg $49.60 · $750,200 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-30 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −15,125 | 230,505 | D |
Loading xslF345X03/doc4.xml…